
FDA Identifies Safety Issue with Philips CPAP Machines, Shares Plummet
Shares of Dutch technology company Philips fell over 6% after the US FDA alerted patients to a new safety issue with machines used for the treatment of obstructive sleep apnea. The problem involves the heating element in the humidifier of the "DreamStation 2" sleep therapy device. Philips had already conducted a review that found 270 complaints over the past three years and had flagged the matter with the FDA. The agency received reports of thermal issues such as fire, smoke, burns, and overheating while using Philips' DreamStation 2 CPAP machines. Around a million DreamStation 2 machines are on the market, and they can continue to be used as long as safety instructions are followed.
